A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers

Clinical trial NCT05893888 · RECRUITING

Trial details

NCT number: NCT05893888
Sponsor: Privo Technologies
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Oral Squamous Cell Carcinoma

Start date: 2024-11-07
Primary completion: 2026-10-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.